Plenty of funding to get us through the next 3-4 data readouts
121 patients treated to date
368 hospitals recruiting to trials
and more...
so many partner sponsored trials we are becoming more than than just a 1.5 billion P/A GBM opportunity but a much larger whole of brain cancer opportunity... and about to start the 7th trial to date:
we have the experience and the resources to see the program through to commercialisation
beginning the final stage to commercialisation
Right at this moment no need for any further CRs as we are in a good financial position and have money through to well into next year
And after years of restructure and set up we are finally late in the game
as we release many more good data readouts we will continue to rerate the MC - how excited the science community has become is really gratifying and when DiPG releases its outstanding results we will become eligible for a PRV worth up to 350 million USD And after recently receiving multiple designations which free carries us on 6 million USD in FDA application costs alone.
much to be excited for in the coming couple of months whilst we read out more data across the brain cancers program and without needing any further capital until mid next year
Can’t wait for the next readout with 3-4 in the next few months - thats one a month on average.
